Cabaltera, Baby Boy .

HRN: 27-59-46  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/07/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/07/2025
08/14/2025
IV
29mg
Q24hours
PSNB Sec To Prematurity
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: